Skip to main content

Notice of alternative medication authorization, November 25, 2021

Legal publications
Updated on

 21 December 2021

This notice was published on November 21, 2021.

Medroxyprogesterone acetate replaces:

  • Apo-Medroxy
  • Novo-Medrone